Critical assessment of thioguanine treatment for inflammatory bowel diseases: Is it time to rehabilitate this treatment?

Author:

Movva Ramya123,Haywood Alison12,Khan Sohil A12,Florin Timothy HJ234,Oancea Iulia234ORCID

Affiliation:

1. School of Pharmacy, Menzies Health Institute; Griffith University; Gold Coast Queensland Australia

2. Mater Research Institute-University of Queensland; Brisbane Queensland Australia

3. Translational Research Institute; Woolloongabba Queensland Australia

4. School of Medicine-University of Queensland; St Lucia Queensland Australia

Funder

National Health and Medical Research Council

Griffith University International Postgraduate Research Scholarship

Griffith University Postgraduate Research Scholarship

Publisher

Wiley

Subject

Gastroenterology

Reference33 articles.

1. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study;Wilson;Inflamm Bowel Dis,2010

2. A clinical review of recent findings in the epidemiology of inflammatory bowel disease;Ponder;Clin Epidemiol,2013

3. Effectiveness research in inflammatory bowel disease: a necessity and a methodological challenge;Salleron;J Crohns Colitis,2016

4. New drugs on the horizon for IBD;Sands;Dig Dis,2014

5. Current limitations of IBD treatment: where do we go from here?;Targan;Ann N Y Acad Sci,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3